Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 modulates microglial activity through regulation of chemokine (C–X3–C) receptor 1 –mediated signalling pathways
Bo Ma, Leyan Xu, Xiaodong Pan, et al.
Human Molecular Genetics (2016) Vol. 25, Iss. 16, pp. 3515-3523
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Parkinson disease
Werner Poewe, Klaus Seppi, Caroline M. Tanner, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 3800
Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration
Carla R.A. Batista, Giovanni Freitas Gomes, Eduardo Candelario‐Jalil, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2293-2293
Open Access | Times Cited: 416
Microglia and astrocyte dysfunction in parkinson's disease
Tae‐In Kam, Jared T. Hinkle, Ted M. Dawson, et al.
Neurobiology of Disease (2020) Vol. 144, pp. 105028-105028
Open Access | Times Cited: 268
Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
Ludovica Iovino, Marie‐Ève Tremblay, Laura Civiero
Journal of Pharmacological Sciences (2020) Vol. 144, Iss. 3, pp. 151-164
Open Access | Times Cited: 260
Microglia Phenotypes in Aging and Neurodegenerative Diseases
Menbere Wendimu, Shelley B. Hooks
Cells (2022) Vol. 11, Iss. 13, pp. 2091-2091
Open Access | Times Cited: 186
Astrocytes, Microglia, and Parkinson’s Disease
Eun-hye Joe, Dong‐Joo Choi, Jiawei An, et al.
Experimental Neurobiology (2018) Vol. 27, Iss. 2, pp. 77-87
Open Access | Times Cited: 125
Glial phagocytic clearance in Parkinson’s disease
Marie‐Ève Tremblay, Mark Cookson, Laura Civiero
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 124
Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration
Heather Wilkins, Ian Weidling, Yan Ji, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 89
LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease
Heyne Lee, William James, Sally A. Cowley
Biochemical Society Transactions (2017) Vol. 45, Iss. 1, pp. 131-139
Open Access | Times Cited: 83
Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
Isabella Russo, Alice Kaganovich, Jinhui Ding, et al.
Neurobiology of Disease (2019) Vol. 129, pp. 67-78
Open Access | Times Cited: 63
Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
Diego Cabezudo, Veerle Baekelandt, Evy Lobbestael
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 61
The Potential Role of Dysfunctions in Neuron-Microglia Communication in the Pathogenesis of Brain Disorders
Katarzyna Chamera, Ewa Trojan, Magdalena Szuster-Głuszczak, et al.
Current Neuropharmacology (2019) Vol. 18, Iss. 5, pp. 408-430
Open Access | Times Cited: 57
Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
Rachel Kelly, Valerie Joers, Malú G. Tansey, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 453-453
Open Access | Times Cited: 57
LRRK2 as a target for modulating immune system responses
Isabella Russo, Luigi Bubacco, Elisa Greggio
Neurobiology of Disease (2022) Vol. 169, pp. 105724-105724
Open Access | Times Cited: 24
Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy
Insup Choi, George R. Heaton, You-Kyung Lee, et al.
Science Advances (2022) Vol. 8, Iss. 43
Open Access | Times Cited: 24
The unlikely partnership between LRRK2 and α‐synuclein in Parkinson's disease
Noémie Cresto, Gardier Camille, Francesco Gubinelli, et al.
European Journal of Neuroscience (2018) Vol. 49, Iss. 3, pp. 339-363
Open Access | Times Cited: 39
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
Sara Belloli, Michele Morari, Valentina Murtaj, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 33
Morphological diversity of microglia: implications for learning, environmental adaptation, ageing, sex differences and neuropathology
Marcus Augusto‐Oliveira, Gabriela de Paula Arrifano, Caio Gustavo Leal-Nazaré, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106091-106091
Closed Access
Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
Tatou Iseki, Yuzuru Imai, Nobutaka Hattori
Biomolecules (2023) Vol. 13, Iss. 1, pp. 178-178
Open Access | Times Cited: 10
The effect of neuroinflammation on the cerebral metabolism at baseline and after neural stimulation in neurodegenerative diseases
Fatima Cheataini, Nissrine Ballout, Tareq Al Sagheer
Journal of Neuroscience Research (2023) Vol. 101, Iss. 8, pp. 1360-1379
Closed Access | Times Cited: 9
Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 response
Jeongho Park, Jang-Won Lee, Scott C. Cooper, et al.
Journal of Leukocyte Biology (2017) Vol. 102, Iss. 4, pp. 1093-1102
Open Access | Times Cited: 30
Leucine-rich repeat kinase-2 (LRRK2) modulates paraquat-induced inflammatory sickness and stress phenotype
Chris Rudyk, Zach Dwyer, Shawn Hayley
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 28
Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements
Longping Yao, Jiayu Wu, Sumeyye Koc, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 23
Mechanisms of Autoimmune Cell in DA Neuron Apoptosis of Parkinson’s Disease: Recent Advancement
Zijian Zheng, Shushan Zhang, Hanwen Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 15
Induced pluripotent stem cell‐based modeling of mutant LRRK2‐associated Parkinson's disease
Beatrice Weykopf, Simone Haupt, Johannes Jungverdorben, et al.
European Journal of Neuroscience (2019) Vol. 49, Iss. 4, pp. 561-589
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top